- DNA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Ginkgo Bioworks (DNA) CORRESPCorrespondence with SEC
Filed: 15 Sep 21, 12:00am
Soaring Eagle Acquisition Corp.
955 Fifth Avenue
New York, NY 10075
September 15, 2021
VIA EDGAR
Division of Corporation Finance
Office of Life Sciences
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: | Soaring Eagle Acquisition Corp. |
Registration Statement on Form S-1, originally filed August 11, 2021
File No. 333-258712
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Soaring Eagle Acquisition Corp. hereby respectfully requests that the effective date of the above-captioned Registration Statement on Form S-1, as amended (the “Registration Statement”), be accelerated to, and that the Registration Statement be declared effective at, 4:00 p.m., prevailing Eastern Time, on September 16, 2021, or as soon as practicable thereafter.
Please contact Joel Rubinstein (joel.rubinstein@whitecase.com / telephone: (212) 819-7642) or Jonathan Rochwarger (jonathan.rochwarger@whitecase.com / telephone: (212) 819-7643) of White & Case LLP with any questions and please notify one or more of them when this request for acceleration has been granted to provide notice of effectiveness.
[Signature Page Follows]
Sincerely, | ||
By: | /s/ Eli Baker | |
Name: Eli Baker | ||
Title: President and Chief Financial Officer |
cc: | Joel Rubinstein, White & Case LLP |
Jonathan Rochwarger, White & Case LLP
[Signature Page to Acceleration Request]